Lausanne, Vaud, Switzerland
GliaPharm is a Swiss biotech that develops innovative therapeutic strategies for neurodegenerative diseases by targeting glial cells in the brain. More info on www.gliapharm.com
Scientist in the Laboratory of Neuroenergetics and Cellular Dynamics (LNDC), EPFL, Lausanne, Switzerland
Postdoctoral research scientist in Prof. Alberini's laboratory, New York University, Center for Neural Science. Modulation of stress on the molecular mechanisms underlying long-term memory
Postdoctoral research scientist at the Center for Psychiatric Neuroscience, Cery Hospital Epigenetic and transcriptional regulations by neurotrophic factors in developing cortical neurons.
Graduate student Dr. Martin's laboratory, Lemanic Neuroscience Doctoral School, University of Lausanne Regulation of dendritic development by neurotrophic factors
Presentation of scientific activities to general audience
Undergrad student, Departement of Biochemistry/World Health Organization and Immunology Research Training Center (WHO-IRTC), University of Lausanne, Switzerland Role of IL-23 and IL-17 in the development of Th1/Th2 responses of mice infected with L.major